The peripheral-type benzodiazepine receptor (PBR) is not only widely expressed throughout the body, but it is also genetically conserved from bacteria to humans. Many functions have been attributed to it, but its primary role remains a puzzle. In the current study, we stably transfected cultures of MA-10 Leydig cells with either control or 18-kDa PBR antisense knockout plasmids. The antisense knockout vector was driven by the human enkephalin promoter, which contains two cAMP response elements, such that cAMP treatment of transfected cells could superinduce 18-kDa PBR antisense RNA transcription and, hence, down-regulate endogenous 18-kDa PBR mRNA levels. Control and knockout MA-10 cell lines were then compared at the level of receptor binding, thymidine incorporation, and steroid biosynthesis. Eighteen-kilodalton PBR knockout reduced the maximal binding capacity of tritium-labeled PBR ligands, and the affinity of receptors to the ligands remained unaltered. Additionally, 24-h accumulation of progesterone was lower in the knockout cells. Exposure of the two cell types to 8-bromo-cAMP resulted in a robust increase in steroid production. However, a complex pattern of steroid accumulation was observed, in which further progestin metabolism was indicated. The later decline in accumulated progesterone as well as the synthesis of androstenedione were different in the two cell types. At the level of cell proliferation, reduction of 18-kDa PBR mRNA showed no effect. Thus, we conclude that the 18-kDa PBR may have a more important role in steroidogenesis than in proliferation in this Leydig cell line.
A broad spectrum of putative functions has been suggested for the PBR (8) , such as regulation of steroid production (4, 8 -12) , involvement in cell growth and differentiation (12) (13) (14) (15) , regulation of the mitochondrial respiratory chain (8, 16, 17) , regulation of heme biosynthesis (8, 18, 19) , effect on the immune and phagocytic host defense response (8, 20) , and modulation of voltage-dependent calcium channels (8) . The first two of these functions are the most commonly suggested. The relative importance of each of these functions is still unclear. Furthermore, it is possible that these functions may show tissue specificity.
In the present study, we focused on the two major putative PBR roles, cell proliferation and steroidogenesis, in MA-10 mouse tumor Leydig cell line. Steroidogenic cells express high levels of PBR, and in such cells the PBR have been associated with steroidogenesis (4, 8 -10, 12) . Accumulated data suggest a role for PBR in the first step of steroidogenesis, namely the production of pregnenolone from cholesterol in the mitochondria. Papadopoulos and co-workers (9, 12) characterized the steroidogenic role of PBR in the MA-10 Leydig cell line. Other studies have demonstrated a role of PBR in the regulation of cell proliferation in different cell lines (2-4, 8, 12-15) .
The 18-kDa PBR gene is composed of four exons, which can express up to two splicing variants of mRNA (21) . By downregulating mRNA levels, one can effectively reduce the amount of 18-kDa PBR protein locally expressed. One approach to depleting the 18-kDa PBR expression is the antisense knockout method (22) . In the current study, we investigated the relative importance of PBR as a regulator of steroidogenesis and cell proliferation in MA-10 cells.
EXPERIMENTAL PROCEDURES

Cells
The MA-10 cell line, originally cloned from the solid M548OP mouse tumor Leydig cells, was a kind gift of Dr. Mario Ascoli (Department of Pharmacology, University of Iowa College of Medicine, Iowa City, IA). MA-10 cell cultures were incubated as described previously (23) . Briefly, cells were maintained in RPMI 1640 medium with L-glutamine, containing 20 mM HEPES buffer, 15% horse serum, and 50 g/ml gentamycin sulfate (all purchased from Beit-Ha'emek Biological Industries, Beit Ha'emek, Israel). MA-10 transfected cells were grown in similar medium, except for the use of 7.5% horse serum and 7.5% fetal calf serum, instead of 15% horse serum. In the experiments in which steroidogenesis was assessed, serum-free medium was used (Dulbecco's modified Eagle's medium plus Ham's F-12 (1:1) medium, containing 15 mM HEPES buffer, 2.4 g/liter NaHCO 3 , 0.1 IU/ml insulin, 5 g/ml transferrin, 0.1 mg/ml glutamine, and 50 g/ml gentamycin (all from Beit-Ha'emek)).
Plasmid Construction
The cDNA encoding the 18-kDa PBR consists of four exons ligated within a Bluescript vector (Stratagene, La Jolla, CA). This plasmid was a kind gift from Dr. Karl E. Krueger (Georgetown University, Washington, D. C.). The antisense vectors were prepared by subcloning the 460-base pair DraI-PvuII exon 3 and 4 fragments of the 18-kDa PBR subunit gene. It was placed into the HincII site of the pENKAT12 plasmid in the antisense orientation with respect to the human enkephalin promoter (pENKPBR-A) (see Fig. 1 ). The human enkephalin promoter-driven chloramphenicol acetyltransferase construct ( Fig. 1) showed relatively high levels of basal expression in MA-10 cells (data not shown). Furthermore, the same promoter-driven construct was inducible by cAMP analogues (24) .
Stable Transfection of MA-10 Cells
The transfection was performed as described previously (22) . Briefly, cells were plated a day before transfection (5 ϫ 10 5 cells/90-mm 2 tissue culture dish). On the following day 15 g of antisense knockout plasmid was routinely cotransfected with 3 g of the neomycin-resistant plasmid pMC1 NEO poly(A) (Stratagene, La Jolla, CA). In control experiments, the plasmid pENKAT12 was used with pMC1 neo poly(A). Four hours after the transfection, the cells were subjected to glycerol shock for 90 s. The day after transfection, G418 (neomycin analogue) selection (300 g/ml) was initiated and maintained for 3 weeks, at the end of which time cell colonies were counted and categorized by colony size. The cells were then plated and subjected to different functional assays. Control and 18-kDa PBR mRNA knockout cells were dubbed EnKat and anti-18-kDa PBR cells, respectively. 5 Ci/mmol; NEN Life Science Products) were used for binding studies, as described previously (25) . Cells were scraped from 90-mm 2 culture dishes, washed with phosphate-buffered saline, and centrifuged at 1200 ϫ g for 5 min. Then the cell pellets were resuspended in 1 ml of 50 mM phosphate buffer, pH 7.4, and centrifuged at 16,000 ϫ g for 30 min.
Binding assays contained 400 l of cell membrane (0.03-0.1 mg of protein/ml) in the absence (total binding) or presence (nonspecific binding) of 1 M unlabeled PK 11195 (Pharmuka Laboratories, Gennevilliers, France) or Ro 5-4864 (Hoffmann-La Roche, Basel, Switzerland), up to a final volume of 500 l. After incubation for 1 h at 4°C, samples were filtered under vacuum over Whatman GF/B filters and washed three times with 3 ml of phosphate buffer. Filters were placed in vials containing 4 ml of xylene-Lumax (3:1, v/v; Lumax was purchased from Lumac, Schaesberg, The Netherlands) and counted for radioactivity in a ␤-scintillation counter after 12 h.
The maximal number of binding sites (B max ) and equilibrium dissociation constants ( 
RNA Isolation and Northern Blot Analysis
RNA was isolated from each of the tissues by the acid guanidinium thiocyanate phenol chloroform method (26) . RNA (10 -50 g) was electrophoresed on 1% agarose-formaldehyde gels and then transferred to Nytran-N (Schleicher & Schuell). After prehybridization for 2 h, membranes were hybridized overnight at 65°C with 32 P-labeled DNA probes (27) , using a 781-base pair EcoRI PBR cDNA fragment. To control for RNA loading variability, membranes were subsequently reprobed with 32 P-labeled glyceraldehyde-3-phosphate dehydrogenase DNA, using a 1600-base pair PstI glyceraldehyde-3-phosphate dehydrogenase fragment (28) . After washing twice with 2 ϫ SSC and 1% SDS for 20 min at 65°C, membranes were exposed for 15 min to a phosphor-imaging screen and analyzed by a phosphor imager (model BAS 1000 MacBos; Fujix, Japan), as well as to x-ray film (Kodak XAR) for 1-3 days at Ϫ80°C.
Cell Proliferation
Cell Count-Cells were plated in 24-well dishes (5 ϫ 10 4 cells/well), trypsinized, and counted visually using a hemocytometer every 24 h over a 6-day period (with and without trypan blue staining). The count determined the doubling time and viability of EnKat and anti-PBR cells.
Thymidine Incorporation-Cell cultures at high density were incu-FIG. 1. Eighteen-kilodalton PBR mRNA plasmid knockout vector construction. The antisense vectors were prepared by the subcloning of the 460-base pair DraI-PvuII, exons 3 and 4-containing fragment of the 18-kDa PBR-subunit cDNA. It was placed into the HincIIcut pENKAT12 plasmid in the antisense orientation with respect to the human enkephalin promoter. bated for 4 days without a change of medium. Cells were then trypsinized and plated in 24-well plates (5 ϫ 10 4 cells/well). One hour later, cells were exposed to a benzodiazepine receptor ligand: clonazepam (with very low affinity for PBR), Ro 5-4864 (with very high affinity for the isoquinoline carboxamide-binding protein and voltagedependent anion channel of the PBR), or the isoquinoline carboxamide derivative PK 11195 (with high affinity for the isoquinoline carboxamide-binding protein of the PBR).
The ligands were dissolved in Me 2 SO. The final concentration of ligands in the wells varied over a wide range (10 Ϫ4 to 10 Ϫ10 M), and the final concentration of Me 2 SO in all wells was 1%. Subjection to the ligands was immediately followed by the addition of 25 l of [ 3 H]methyl thymidine (5 Ci/mmol; Rotem Industries, Beer Sheva, Israel) to a final concentration of 1 M. Cells were incubated for 16 or 26 h, and then each well was washed three times with ice-cold phosphate-buffered saline, incubated with 500 l of 10% trichloroacetic acid for 30 min at 4°C, and incubated overnight with 500 l of 1 N NaOH. From each well, 300 l of extract was put into a vial with 4 ml of scintillation solution and counted in a ␤-counter.
Steroid Biosynthesis
Cells were plated in 24-well plates (2 ϫ 10 5 cells/well) and incubated overnight. On the following day, cells were washed twice with 1 ml of serum-free medium and then incubated overnight with 1 ml of serumfree medium. A second wash with 2 ml of serum-free medium was performed on the following day, and cells were incubated with 1 ml of serum-free medium for 4, 8, 12 , and 24 h. Sometimes, 1 mM of 8-bromocAMP (Sigma) was added to each well. At the end of each incubation period, media were collected from all wells, and steroids were measured by radioimmunoassay. Progesterone, 20␣-dihydroprogesterone (20␣-DHP), and estrone were estimated as described by Bauminger et al. (29) , and for androstenedione determination a commercial kit (Diagnostic Systems Laboratories, Webster, TX) was used.
Where steroid concentrations are presented (Figs. 4 and 5) , n is the total number of similarly treated wells, collected in 1-4 independent experiments. When results from 2-4 experiments were combined, normalization was first conducted within each experiment: Values from individual wells were divided by the mean steroid concentration observed for EnKat cells at 8 h in the same experiment. This mean value was defined as 1, 100, or 1000, so that it would be close to the absolute value (expressed as ng/ml) of this mean.
A representative cell count (n ϭ 6) in serum-free medium conditions was performed as a cell viability test. Cells were plated in 24-well plates (2 ϫ 10 5 cells/well) and incubated overnight. On the following day, cells were washed and incubated overnight with serum-free medium. Next, cells were washed again, incubated with serum-free medium, and then trypsinized and visually counted using a hemocytometer at zero time and after 4, 8, 12 , and 24 h.
Statistical Analysis
Results are expressed as mean Ϯ S.E. Two-and one-way analysis of variance, Student-Newman-Keuls post hoc analysis, and nonparametric Mann-Whitney and Kruskal-Wallis tests were used as appropriate. (Fig. 2, D-F) . As shown in Fig. 2A, reduced (50% (Fig. 2D) .
Representative saturation curves and the corresponding Scatchard analyses are depicted in Fig. 2, B Northern blot analysis showed an indication toward a reduced 18-kDa PBR mRNA level in knockout MA-10 cells as compared with the control cells.
Effect of 18-kDa PBR Knockout on DNA Synthesis and Cell
Growth-Involvement in cell proliferation is one of the putative functions of PBR. We examined the effect of the mRNA 18-kDa PBR knockout on the spontaneous proliferation of MA-10 tumor Leydig cells. When cell counts of EnKat and anti-18-kDa PBR cells were compared over a 6-day period, no statistically significant differences between the two cell types were observed. Both EnKat and anti-18-kDa PBR cells exhibited a doubling time of 24 h. In other experiments (Fig. 3) , thymidine incorporation was estimated in both types of transfected cells, in the absence and presence of a benzodiazepine receptor ligand (clonazepam, PK 11195, or Ro 5-4864) (Fig. 3 ). Cells were subjected to a wide range of concentrations of the three ligands (10 Ϫ10 to 10 Ϫ4 M) throughout two incubation periods (16 and 26 h). First, a comparison was made between the two cell types in the absence of drugs. For each experiment, the mean cpm/ well was calculated for each of the four control groups (two cell types and two incubation periods). Results of four independent experiments were then combined (mean Ϯ S.E.; n ϭ 4). Cell cultures were then treated with 8-bromo-cAMP (1 mM) for 4 -24 h. In subjecting the transfected cells to 8-bromocAMP, we used conditions that had been found to superinduce the human enkephalin promoter via the cAMP response element (24) . Hence, under these conditions there should be considerably more cellular production of anti-18-kDa PBR mRNA. At the same time, 8-bromo-cAMP was expected to greatly stimulate progestin production. As shown in Fig. 4B , for EnKat cells progesterone levels reached a peak at 12 h and then dropped to low levels at 24 h. This drop was not a result of the conversion of the progesterone to its main metabolite, 20␣-DHP (33), since 20␣-DHP concentration also dropped sharply between 12 and 24 h (Fig. 5B) . In anti-18-kDa PBR cells, progesterone levels in the medium decreased already at 12 h, thus resulting in much lower levels compared with EnKat cells. This difference was maintained at 24 h (Fig. 4B) .
In contrast to progesterone, 20␣-DHP in anti-18-kDa PBR cells was the same as in EnKat cells (Fig. 5B) . Androstenedione was then determined in these media samples. The results for 8-bromo-cAMP-treated cells are presented in Fig. 5C . The amounts of secreted androstenedione were much lower than those of progesterone and 20␣-DHP, in agreement with the original finding of Ascoli (30) . The pattern of androstenedione secretion was different from that of the progestins. There was no decrease in androstenedione concentration between 12 and 24 h. Furthermore, androstenedione secreted by anti-18-kDa PBR cells was significantly lower compared with EnKat cells at all time points. Basal androstenedione concentration was near the detection level (see legend to Fig. 5C ). Estrone was also estimated in the same medium samples and was undetectable (Ͻ60 pg/well in 8-bromo-cAMP-treated cells at 24 h). Thus, androstenedione and estrone did not compensate for the precipitous decrease in secreted progestin concentration.
DISCUSSION
The approach we used to investigate the contribution of the 18-kDa PBR subunit to Leydig cell proliferation versus steroidogenesis involved creating a plasmid vector capable of produc- 
18-kDa PBR Antisense Knockout in MA-10 Cells
ing antisense 18-kDa PBR RNA. This exogenous RNA would hybridize with endogenous 18-kDa PBR mRNA, effectively preventing it from replenishing 18-kDa PBR protein. Any important effects 18-kDa PBR might have should then be distinguishable by comparing the particular function of interest in cells containing the 18-kDa PBR antisense vector compared with parallel cultures transfected with control vectors. This study was carried out similarly to previous studies in which the focus was on other genes (22) .
To determine whether MA-10 cells receiving the knockout and control vectors would express 18-kDa PBR differently, receptor-binding studies were carried out. Indeed, an approximately 50% reduction in the binding of [ 3 H]PK 11195 was observed in cells expressing the knockout vector, compared with control. We believe that the reason the effect was not complete was that the promoter used to drive the transcription of antisense 18-kDa PBR RNA was not, in untreated MA-10 cells, as strong a promoter as others for this cell type. According to a number of studies, the isoquinoline-binding site may overlap with the benzodiazepine-binding site, but it is not identical (31) (32) (33) (34) (35) . The latter may also reside on the 32-kDa voltage-dependent anion channel, a subunit of the PBR complex (31) . To address this issue, we compared the binding of the PBR-specific ligand [ 3 H]Ro 5-4864 in these modified cells. In our hands (see Fig. 2, D-F) , no significant difference in binding was found between control and 18-kDa PBR subunit knockout cultures. This indicates that, while the 18-kDa PBR subunit is necessary for PBR isoquinoline binding, it may not be absolutely essential for PBR-specific benzodiazepine binding. This could be explained either by the overlapping benzodiazepine/isoquinolinebinding site hypothesis (as mentioned above (31-35)) and/or the presence of two benzodiazepine-binding sites in this receptor complex.
We investigated the putative role of the 18-kDa subunit of PBR in cell proliferation using the incorporation of [ 3 H]thymidine into proliferating cells as our primary tool (Fig. 3) . To confirm the findings, we also counted cells of both types over five doubling periods. Our data very clearly showed that there were no overt differences between control and knockout cultures following any of the treatments presented in Fig. 3 , as well as without drug addition. This would indicate that the 18-kDa PBR subunit is probably not involved in the regulation of Leydig cell proliferation. In the same series of experiments, a very significant inhibition of cell proliferation was observed at the highest concentration of the drugs used (10 Ϫ4 M). This was observed for control as well as knockout cultures and with PBR-specific drug treatments as well as central benzodiazepine receptor-specific treatments. These effects may be nonspecific, since 10 Ϫ4 M is a very high concentration. Alternatively, these data are consistent with the putative presence of another type of benzodiazepine receptor that does not contain the 18-kDa PBR subunit. Such a notion has already been suggested, in theory (15) .
Papadopoulos and colleagues (9, 12) have previously shown a link between PBR expression in MA-10 Leydig cells and steroidogenesis. Specifically, they claim that the PBR is involved in cholesterol transport across the mitochondrial membrane (36), a step considered to be rate-limiting in steroid biosynthesis. They showed that incubation of MA-10 cells with various benzodiazepine receptor ligands stimulated steroidogenesis; the magnitude of this stimulation correlated significantly with the drug's binding affinity to the PBR. Furthermore, the addition of PBR ligands to isolated mitochondria (but not to mitochondrial preparations lacking the outer membrane) resulted in increased pregnenolone production (9) .
In another study, elimination of diazepam-binding inhibitor, allegedly the endogenous ligand of PBR, by introduction of an antisense oligodeoxynucleotide, entirely inhibited human chorionic gonadotropin-stimulated steroidogenesis (10) . On the other hand, the stimulatory effect of 22(R)-hydroxycholesterol, a mitochondria-permeable cholesterol derivative, was not af- A, media from untreated cells were collected, and the concentration of 20␣-DHP was measured by radioimmunoassay. Data were normalized as described under "Experimental Procedures." The absolute value used for normalization (expressed as ng/ml) was 1.61 Ϯ 0.61 (mean Ϯ S.E. of three independent experiments). Within either cell type, 20␣-DHP at the various time points differed significantly (p Ͻ 0.0001), using the Kruskal-Wallis nonparametric test. B, media from treated cells were collected, and results from one experiment are presented (mean Ϯ S.E.). No statistically significant difference was observed between the two cell types at any time point. However, 20␣-DHP concentrations changed over time (p Ͻ 0.002 for EnKat cells and p Ͻ 0.001 for anti-18-kDa PBR; Kruskal-Wallis test). C, media from treated cells were collected, and the concentration of androstenedione was measured by radioimmunoassay. Results were normalized as described under "Experimental Procedures." The absolute value used for normalization (expressed as ng/ml) was 60 Ϯ 32 (mean Ϯ range for two independent experiments). Within either cell type, androstenedione at various time points differed significantly (p Ͻ 0.001; Kruskal-Wallis nonparametric test). In these experiments, basal androstenedione concentrations at 24 h were also estimated (experiment 1, 56 Ϯ 9 and 41 Ϯ 5 pg/well in EnKat and anti-18-kDa PBR cells, respectively (n ϭ 10); experiment 2, 18 Ϯ 2 and 14 Ϯ 3 pg/well in EnKat and anti-18-kDa PBR cells, respectively (n ϭ 11)). *, p Ͻ 0;02; **, p Ͻ 0.005; ***, p Ͻ 0.001 versus EnKat cells at the same time point (Mann-Whitney nonparametric test).
fected. In our study, there was a significant reduction (about 20%) in basal progesterone and 20␣-DHP levels in the medium of 18-kDa PBR knockout cell cultures, compared with EnKat cells (Figs. 4A and 5A ). This difference in progestin levels was found at 24 h.
As observed before (30) , in 8-bromo-cAMP-stimulated cells progesterone production was increased by more than 100-fold. However, the pattern of progesterone concentrations in the medium of both cell types was unusual in that, after an initial increase, it decreased with time. Such findings would indicate that secreted progesterone is further metabolized. Ascoli (30) , in his characterization of the original MA-10 cell line, described a somewhat similar phenomenon. With treatment leading to protein kinase A activation, progesterone concentration modestly decreased between 8 and 12 h of incubation. In his study, the formation of 20␣-DHP could account for most of this decrease (30) . In our study, at 24 h the decrease was much greater, and 20␣-DHP decreased as well. Thus, conversion of progestins to another metabolite(s) has to be postulated. At present, these putative metabolites are not identified. Metabolism of progesterone to androstenedione by 17␣-hydroxylase, 17,20-lyase, and then conversion of androstenedione to estrone, by aromatase, are relatively slow and thus cannot be the only step involved. In any event, these conversions of progesterone were significantly different in EnKat and the 18-kDa PBR knockout cells; the rate of fall in progesterone concentration in the medium was greater in the latter cells. 20␣-DHP, however, decreased at the same rate in both cell types.
The effect of 18-kDa PBR knockout on androstenedione was different from that on either progestin. Secreted androstenedione was significantly lower in anti-18-kDa PBR cells even at the earliest time point examined (4 h). This difference persisted throughout the rest of the incubation period, in which no absolute decline in concentration of the androgen was observed. Thus, here the 18-kDa PBR could be affecting androstenedione synthesis rather than metabolism. Still, a determination of a much greater array of steroid metabolites is necessary for the complete identification of the enzymatic steps affected by the knockout of 18-kDa PBR.
The PBR are not the only proteins thought to be involved in cholesterol transport in the mitochondria. Steroidogenic acute regulatory protein, a 37-kDa protein localized in the mitochondria, has recently been cloned (37) . The production of this labile protein is stimulated by cAMP. The steroidogenic acute regulatory protein is apparently the long sought mediator of the acute stimulation of steroidogenesis by tropic hormones. It may be that the 18-kDa PBR act in concert with steroidogenic acute regulatory protein in steroid biosynthesis. It is possible that a very marked reduction in PBR is required for impairment of the steroidogenic response to cAMP. Thus, the modest reduction in ligand binding observed in the anti-18-kDa PBR cells is not sufficient for obtaining an unequivocal reduction in the rate of progestin production in MA-10 cells. We intend to further study the correlation between the reduction in PBR gene expression and steroidogenesis in clones of knockout MA-10 cells, in which the extent of PBR knockout is much more marked.
In summary, further studies are needed to confirm the involvement of the 18-kDa PBR subunit in MA-10 Leydig cell steroid biosynthesis; however, we have shown that cell proliferation is independent of 18-kDa PBR subunit gene expression.
Other functions have been suggested to involve the 18-kDa PBR subunit, and there are cells where the PBR is expressed but steroidogenesis is not present. These data suggest that there may be other tissue-specific functions of the PBR that warrant further investigation.
